Atricure Inc. buy UBS Group AG
Start price
16.02.24
/
50%
€37.80
Target price
16.02.25
€53.79
Performance (%)
-
End price
17.02.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Atricure Inc. | 6.780% | 6.780% | -39.032% |
| iShares Core DAX® | 0,44 % | 5,90 % | 8,05 % |
| iShares Nasdaq 100 | 1,06 % | 0,92 % | 28,47 % |
| iShares Nikkei 225® | 1,77 % | 1,23 % | 47,57 % |
| iShares S&P 500 | 0,37 % | 1,92 % | 23,20 % |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its price target raised by analysts at UBS Group AG from $57.00 to $58.00. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat
In the thread Trading Atricure Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten